Drug prices projected to jump 7.35% for hospitals

Daniel Allar | February 06, 2018 | Cardiovascular Business | Economics

Pharmaceutical consulting company Vizient expects drug prices for hospitals to rise 7.35 percent between July 2018 and the same time next year.

The increase is slightly lower than in previous years, reflecting fewer products projected to see “exorbitant” price hikes, according to Vizient’s report.

“While slightly lower, this increase still represents a substantial impact, especially given the use of many high-cost drugs across our members,” Dan Kistner, senior vice president of pharmacy solutions for Vizient, said in a press release.

Find more on the story at HealthExec:

Hospitals can expect 7.35% increase in drug prices

Daniel Allar

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Drug prices projected to jump 7.35% for hospitals

Related Content

Around the web